Showing 38,381 - 38,400 results of 102,076 for search '(( 10 ng decrease ) OR ( 5 ((((wt decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.62s Refine Results
  1. 38381

    Utilizing reduction in spheroid counts and/or total nuclear intensity to determine toxic effects of compounds. by Pranjali Beri (14945400)

    Published 2023
    “…They are indicated appropriately in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0287809#pone.0287809.g004" target="_blank">Fig 4</a>. …”
  2. 38382

    Synthesis of a Dialuminum-Substituted Silicotungstate and the Diastereoselective Cyclization of Citronellal Derivatives by Yuji Kikukawa (1929586)

    Published 2008
    “…The reaction of <b>1</b> with pyridine yielded TBA<sub>3</sub>[(C<sub>5</sub>H<sub>5</sub>N)H][γ-SiW<sub>10</sub>O<sub>36</sub>{Al(C<sub>5</sub>H<sub>5</sub>N)}<sub>2</sub>(μ-OH)<sub>2</sub>]·2H<sub>2</sub>O (<b>2</b>), and the molecular structure was successfully determined by the X-ray crystallographic analysis. …”
  3. 38383

    Synthesis of a Dialuminum-Substituted Silicotungstate and the Diastereoselective Cyclization of Citronellal Derivatives by Yuji Kikukawa (1929586)

    Published 2008
    “…The reaction of <b>1</b> with pyridine yielded TBA<sub>3</sub>[(C<sub>5</sub>H<sub>5</sub>N)H][γ-SiW<sub>10</sub>O<sub>36</sub>{Al(C<sub>5</sub>H<sub>5</sub>N)}<sub>2</sub>(μ-OH)<sub>2</sub>]·2H<sub>2</sub>O (<b>2</b>), and the molecular structure was successfully determined by the X-ray crystallographic analysis. …”
  4. 38384

    Bacterial strains used in this study. by Malin-Theres Seffer (14808772)

    Published 2023
    “…<i>aureus</i> in human plasma was approximately 5 x 10<sup>8</sup> cells.</p><p>Conclusions</p><p>The Seraph affinity filter, based on heparin-coated beads, is a highly efficient method for reducing <i>S</i>. …”
  5. 38385

    Stability of FeF<sub>3</sub>‑Based Sodium-Ion Batteries in Nonflammable Ionic Liquid Electrolytes at Room and Elevated Temperatures by Zifei Sun (11576725)

    Published 2022
    “…The Pyr<sub>1,4</sub>FSI electrolyte demonstrated the best cycling stability with an unprecedented decay rate of only ∼0.023% per cycle after the initial stabilization and an average coulombic efficiency of ∼99.5% for over 1000 cycles at RT. The Pyr<sub>1,3</sub>FSI electrolyte demonstrated the best cycling stability with a capacity decay rate of only ∼0.25% per cycle at 60 °C. …”
  6. 38386
  7. 38387
  8. 38388

    Ultrahigh Recovery of Fracture Strength on Mismatched Fractured Amorphous Surfaces of Silicon Carbide by Junfeng Cui (4382872)

    Published 2019
    “…The potential energy increases 2.6 eV in the reorganized Si–C bonds and decreases by 3.2 and 1.9 eV, respectively, in the formed Si–C and Si–Si bonds. …”
  9. 38389

    Ultrahigh Recovery of Fracture Strength on Mismatched Fractured Amorphous Surfaces of Silicon Carbide by Junfeng Cui (4382872)

    Published 2019
    “…The potential energy increases 2.6 eV in the reorganized Si–C bonds and decreases by 3.2 and 1.9 eV, respectively, in the formed Si–C and Si–Si bonds. …”
  10. 38390

    Ultrahigh Recovery of Fracture Strength on Mismatched Fractured Amorphous Surfaces of Silicon Carbide by Junfeng Cui (4382872)

    Published 2019
    “…The potential energy increases 2.6 eV in the reorganized Si–C bonds and decreases by 3.2 and 1.9 eV, respectively, in the formed Si–C and Si–Si bonds. …”
  11. 38391
  12. 38392

    ABCA1 plays a key role in the inhibition of HCV infection. by Simone Bocchetta (539356)

    Published 2014
    “…<p>(A) Silencing of ABCA1. Huh7.5 cells were transfected with siRNA that targets ABCA1, or with a control siRNA. …”
  13. 38393

    Image_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  14. 38394

    Table_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  15. 38395

    Table_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  16. 38396

    Table_3_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  17. 38397

    Image_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  18. 38398

    <i>Foxj1</i> as a target gene for RFX4. by Ping Xu (122619)

    Published 2018
    “…<p>(A) qPCR. <i>Foxj1</i> mRNA levels were decreased in E12.5 KO brains, whereas there were no significant differences in <i>Ift172</i>, <i>Thbs</i>, <i>Dync2li1</i>, <i>Rfx2</i>, <i>Rfx3</i> mRNAs, and almost undetectable <i>Rfx4</i> transcripts compared to the controls (P< 0.0001, n = 5). …”
  19. 38399

    AS-IV attenuated Aβ1-42-induced mitochondrial dysfunction. by Qinru Sun (573895)

    Published 2014
    “…Mitochondria were counterstained with Mitotracker Green (green fluorescence). (a) vehicle; (b) 50 µM AS-IV; (c) 5 µM Aβ1-42; (d, e, f) 10, 25, 50 µM AS-IV+ 5 µM Aβ1-42, respectively. …”
  20. 38400

    A stratified transcriptomics approach for adipose tissue-specific gene enrichment. by Nicholas M. Morton (206471)

    Published 2011
    “…From top to bottom; 1. differential gene expression (>1.5-fold) between the lines across all adipose tissues was analysed with a ‘snap-shot’ pooled transcriptomics approach. 2. …”